A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Background: Gastric cancer (GC) is one of the most common cancer worldwide. It is essential to identify non-invasive diagnostic and prognostic biomarkers of GC. The aim of the present study was to screen candidate biomarkers associated with the pathogenesis and prognosis of GC by a novel strategy. Methods: The expression level of gene higher in cancer than in adjacent non-cancer tissue was defined as “positive”, and the top 5% genes with “positive rate” were filtered out as candidate diagnostic biomarkers in three Gene Expression Omnibus (GEO) datasets. Further, a prognostic risk model was constructed by multivariate Cox regression analysis in GEO dataset and validated in The Cancer Genome Atlas (TCGA). The expression level of candidate biomarkers was determined in serum and serum-derived exosomes of GC patients. Moreover, the effect of biomarkers in exosomes on migration of GC cells was analyzed by transwell assay. Results: Ten candidate biomarkers (AGT, SERPINH1, WNT2, LIPG, PLAU, COL1A1, MMP7, MXRA5, CXCL1 and COL11A1) were identified with efficient diagnostic value in GC. A prognostic gene signature consisted of AGT, SERPINH1 and MMP7 was constructed and showed a good performance in predicting overall survivals in TCGA. Consistently, serum levels of the three biomarkers also showed high sensitivity and specificity in distinguishing GC patients from controls. In addition, the expression level of the three biomarkers were associated with malignant degree and decreased after surgery in GC patients. Moreover, the expression level of AGT and MMP7 in exosomes correlated positively with serum level. The exosomes derived from serum of GC patients can promote migration of SGC‐7901 cells. After neutralized the expression level of three proteins in exosomes with antibodies, the migration of GC cells was obviously suppressed. Conclusions: Our findings provided a novel strategy to identify diagnostic biomarkers based on public datasets, and suggested that the three-gene signature was a candidate diagnostic and prognostic biomarker for patients with GC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study using a prognostic risk model by multivariate Cox regression analysis in GEO datasets GSE15459 investigated potential prognostic genes [18]. A total of eight genes significantly related to survival were identified”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“suggesting that exosomal AGT and MMP7 may be useful biomarkers for GC prognosis and included in GC progression.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“decreased survival was significantly associated with AGT, SERPINH1, and MMP7”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 35 · Cited by 29
Research works printed but not linked: 1
- Tatsuta M, Itoh T, Okuda S, Yamamura H, Baba M, Tamura H. Carcinoembryonic antigen in gastric juice as an aid in diagnosis of early gastric cancer. Cancer. 1980;46(12):2686–92. · doi:10.1002/1097-0142(19801215)46:12<2686::aid-cncr2820461225>3.0.co;2-e
Metadata
- Authors
- Liu, L., Pang, H., He, Q., Pan, B., Sun, X., Shan, J., Wu, L., Wu, K., Yao, X., & Guo, Y.
- Affiliations
- Third People's Hospital of Chengdu (CN)
- Southwest Jiaotong University (CN)
- University of Electronic Science and Technology of China (CN)
- Qinzhou Maternity and Child Health Care Hospital (CN)
- Corresponding author
- Liu, Lei
- Guo, Yuanbiao
- Venue
- Cancer Cell International
- Published
- 2021-07-02
- Volume
- 21
- Issue
- 1
- Pages
- 335-335
- ISSN
- 1475-2867 (ISSN-L)
- PMC
- PMC8254335
- OpenAlex
- W3175971135
- Cited by
- 29
- References
- 35
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 9 · 2023: 9 · 2022: 3 · 2021: 1
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cancer Cell International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Department of Science and Technology of Sichuan Province (2020YFS0492)
- Applied Basic Research Program of Sichuan Province (2020YJ0485)
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Keywords
- gastric cancer, diagnostic biomarkers, prognostic factors, serum exosomes, gene expression signatures, AGT, HSP47, MMP-7, cell migration, overall survival, non-invasive diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer. https://app.cochat.ai/papers/10.1186/s12935-021-02007-6
- The paper
- Liu, L., Pang, H., He, Q., Pan, B., Sun, X., Shan, J., Wu, L., Wu, K., Yao, X., & Guo, Y. (2021). A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer. Cancer Cell International. https://doi.org/10.1186/s12935-021-02007-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.